Iran Press/ Iran news: Mohammad-Reza Salehi, a faculty member of Tehran University of Medical Sciences and supervisor of the clinical trial of the COVIran Barekat vaccine, said: "The effectiveness of Barekat vaccine on Delta coronavirus was evaluated in a neutralization test (CVNT)."
A neutralization test detects neutralizing antibodies (NAbs) in a patient’s blood.
Salehi added: "It was found that people who received COVIran Barekat vaccine in phases one and two, have an effective antibody against Delta coronavirus."
Salehi said: "The first Iranian coronavirus vaccine had already defeated the UK and South African variants of the coronavirus, and we are preparing an article on it to publish the scientific results."
207/214
Read More:
2nd phase of 'Razi COV-Pars' vaccine clinical trial performed
Pictures of COVIran Barekat vaccine injection in Sistan and Baluchestan
Iran increases production of COVIran Barekat vaccine
